Patients with the cancers acute myelogenous leukemia (AML) and non-Hodgkins lymphoma (NHL) fall into several subtypes. Mechanistic models of how therapies, environment and genotype affect clinical outcome in AML and NHL patients are needed. Development of these models requires measuring data on transcription, signaling and protein interactions from patients in various stages of disease. This is a daunting task due to the complexity of mammalian cells. In collaborative research project 1 (RP1, Dynamic State Space Modeling of Cancer Cell Response to Therapy), we will carry out synchronized experiments to measure protein abundance, protein-interactions and protein modification in genetically defined animal models of AML and NHL in years 1-4 and in human samples in year 5. These measurements will be integrated using new computational methods to analyze the topology of regulatory and signaling networks and dynamic parameters of these networks. To facilitate this analysis, our experiments will be collected as time series and different measurement technologies (i.e., measurements of protein modification, protein levels and protein interactions) will be carried out on cells drawn from synchronized samples. This strict coordination of samples across genomic measurement technologies will enable the integration of our combined dataset into predictive molecular networks that can be used by RP2 and RPS (projects that model the evolution and spatial growth of the tumor explicitly) to predict cell state given tumor microenvironment, genotype and treatment. Our team includes primary developers of genomics technologies and our novel capabilities include scalable methods for making biochemically detailed measurements of real-time protein interaction, technologies for measuring the abundance and types of protein modifications, novel methods for shotgun proteomics and new methods for reconstructing regulatory networks. The project will be defined by our strict focus on proteins/genes critical for tumor development and proteins active in AML and NH which will insure the clinical relevance of our models.

Public Health Relevance

Patients with the cancers acute myelogenous leukemia (AML) and non-Hodgkins lymphoma (NHL) have dramatic differences in response to therapy and in progression and prognosis. By describing a dynamic model of the molecular and regulatory responses of these cancers, we will provide a means for predicting response to therapy based on an individual's genotype and molecular phenotype.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54CA143907-04
Application #
8381746
Study Section
Special Emphasis Panel (ZCA1-SRLB-9)
Project Start
Project End
Budget Start
2012-08-01
Budget End
2013-07-31
Support Year
4
Fiscal Year
2012
Total Cost
$1,164,365
Indirect Cost
$412,462
Name
University of Southern California
Department
Type
DUNS #
072933393
City
Los Angeles
State
CA
Country
United States
Zip Code
90089
Flinders, Colin; Lam, Larry; Rubbi, Liudmilla et al. (2016) Epigenetic changes mediated by polycomb repressive complex 2 and E2a are associated with drug resistance in a mouse model of lymphoma. Genome Med 8:54
Sims, Lee B; Curtis, Louis T; Frieboes, Hermann B et al. (2016) Enhanced uptake and transport of PLGA-modified nanoparticles in cervical cancer. J Nanobiotechnology 14:33
Lee, Jung-Rok; Sato, Noriyuki; Bechstein, Daniel J B et al. (2016) Experimental and theoretical investigation of the precise transduction mechanism in giant magnetoresistive biosensors. Sci Rep 6:18692
Juarez, Edwin F; Lau, Roy; Friedman, Samuel H et al. (2016) Quantifying differences in cell line population dynamics using CellPD. BMC Syst Biol 10:92
Baugh, Evan H; Simmons-Edler, Riley; Müller, Christian L et al. (2016) Robust classification of protein variation using structural modelling and large-scale data integration. Nucleic Acids Res 44:2501-13
Li, Yulin; Deutzmann, Anja; Choi, Peter S et al. (2016) BIM mediates oncogene inactivation-induced apoptosis in multiple transgenic mouse models of acute lymphoblastic leukemia. Oncotarget 7:26926-34
Garvey, Colleen M; Spiller, Erin; Lindsay, Danika et al. (2016) A high-content image-based method for quantitatively studying context-dependent cell population dynamics. Sci Rep 6:29752
Lee, Jung-Rok; Bechstein, Daniel J B; Ooi, Chin Chun et al. (2016) Magneto-nanosensor platform for probing low-affinity protein-protein interactions and identification of a low-affinity PD-L1/PD-L2 interaction. Nat Commun 7:12220
Chiu, Chi-Li; Patsch, Katherin; Cutrale, Francesco et al. (2016) Intracellular kinetics of the androgen receptor shown by multimodal Image Correlation Spectroscopy (mICS). Sci Rep 6:22435
Hosoya, Hitomi; Dobroff, Andrey S; Driessen, Wouter H P et al. (2016) Integrated nanotechnology platform for tumor-targeted multimodal imaging and therapeutic cargo release. Proc Natl Acad Sci U S A 113:1877-82

Showing the most recent 10 out of 110 publications